Mivebresib
Mivebresib (ABBV-075) is a potent and selective BET bromodomain inhibitor that displaces BET proteins from acetylated chromatin, suppressing oncogenic transcription factors like MYC and TMPRSS2-ETS fusions. It demonstrates robust antitumor activity in preclinical models of hematologic malignancies and solid tumors, supporting its investigation in cancer research.
Product Specifications
CAS Number
1445993-26-9
Product Name Alternative
Inhibitor, EpigeneticReaderDomain, Epigenetic Reader Domain, inhibit, Mivebresib, ABBV 075, ABBV-075, ABBV075, Apoptosis, BET
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
97.17% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.18 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:250 mg/mL (544.11 mM)
Smiles
O (C1=C (C=2C3=C (C (=O) N (C) C2) NC=C3) C=C (NS (CC) (=O) =O) C=C1) C4=C (F) C=C (F) C=C4
Molecular Formula
C22H19F2N3O4S
Molecular Weight
459.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP-0020 1 Each
High Sensitive Northern Blot Probes : miR-21-5p (HS)
Sign In for Pricing
View Details